Impaired circulating myeloid CD1c+ dendritic cell function in human glioblastoma is restored by p38 inhibition – implications for the next generation of DC vaccines

Current treatments for glioblastoma (GBM) have limited efficacy and significant morbidity and therefore new strategies are urgently needed. Dendritic cells have the power to create anti-tumor immune responses. The greater potency of circulating dendritic cells (DC) over laboratory-generated monocyte...

Descripción completa

Detalles Bibliográficos
Autores principales: Adhikaree, Jason, Franks, Hester Ann, Televantos, Constantinos, Vaghela, Poonam, Kaur, Aanchal Preet, Walker, David, Schmitz, Marc, Jackson, Andrew Mark, Patel, Poulam Manubhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527277/
https://www.ncbi.nlm.nih.gov/pubmed/31143512
http://dx.doi.org/10.1080/2162402X.2019.1593803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527277/
https://www.ncbi.nlm.nih.gov/pubmed/31143512
http://dx.doi.org/10.1080/2162402X.2019.1593803

Ejemplares similares